Department of Oral & Maxillofacial Surgery, Barzilai Medical Center, Ashkelon, Israel.
Institute of Pathology, Rabin Medical Center, Petach-Tiqva, Israel.
Head Neck Pathol. 2022 Jun;16(2):388-393. doi: 10.1007/s12105-021-01368-8. Epub 2021 Aug 10.
We aimed to collect and analyze available cases of intraoral acantholytic squamous cell carcinoma (aSCC), that consisted of the authors' cases and cases derived from the existing literature, with an emphasis on the pathological staging and patient outcome. Our research question was whether aSCC is more aggressive than conventional SCC. The literature was searched for documented cases of aSCC involving the intra-oral mucosa, excluding those from the lips and tonsils, and seven new cases were added from our files. The authors compared the obtained aSCC data to existing data for conventional SCC. Fisher Exact or Pearson's χ tests were used for categorical variables. Fifty-five cases of intraoral aSCC were reviewed, of which 48 were retrieved from the literature. Analysis of the published cases was reinforced by contacting the authors of all the papers with incomplete data for further clarifications. The most common sites of aSCC were the tongue (24/55) and the maxilla/maxillary gingiva and/or palate (11/55). The overall survival rate was 36/53 (67.9%) with a mean follow-up period of 22 months against 62.5% for conventional SCC (p = 0.6). No statistically significant difference between the two variants of the tumor with respect to the oral cavity was detected. The differences in age, sex, survival rate, staging, and locations were not statistically significant. Based on the available data from 55 cases, there is no evidence to suggest that aSCC is more aggressive than conventional SCC in intraoral cases.
我们旨在收集和分析现有的口腔内棘层松解性鳞状细胞癌(aSCC)病例,这些病例包括作者的病例和来自现有文献的病例,重点是病理分期和患者预后。我们的研究问题是 aSCC 是否比传统 SCC 更具侵袭性。我们检索了涉及口腔黏膜的 aSCC 病例文献,不包括唇和扁桃体的病例,并从我们的档案中增加了 7 例新病例。作者将获得的 aSCC 数据与传统 SCC 的现有数据进行了比较。对于分类变量,使用 Fisher 确切检验或 Pearson χ 检验。回顾了 55 例口腔内 aSCC 病例,其中 48 例来自文献。通过联系所有数据不完整的论文作者进行进一步澄清,对已发表病例的分析进行了补充。aSCC 最常见的部位是舌(24/55)和上颌/上颌牙龈和/或腭(11/55)。总体生存率为 36/53(67.9%),平均随访时间为 22 个月,而传统 SCC 为 62.5%(p=0.6)。在口腔内两种肿瘤变体之间未检测到统计学上的显著差异。年龄、性别、生存率、分期和位置的差异无统计学意义。基于 55 例病例的现有数据,没有证据表明口腔内 aSCC 比传统 SCC 更具侵袭性。